Rosli Rosliana, Dali Ahmad Fauzi, Abd Aziz Noorizan, Abdullah Amir Heberd, Ming Long Chiau, Manan Mohamed Mansor
Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARA Selangor, Malaysia.
Department of Environmental Health, Faculty of Health Sciences, Universiti Teknologi MARA Bertam, Malaysia.
Front Pharmacol. 2017 Feb 8;8:27. doi: 10.3389/fphar.2017.00027. eCollection 2017.
Despite limited evidence on safety and efficacy of drug use in neonates, drugs are extensively used in this age group. However, the availability of information on drug consumption in neonates, especially inpatient neonates, is limited. This paper systematically reviews published studies on drug utilization in hospitalized neonates. A systematic literature review was carried out to identify observational studies published from inception of databases used till August 2016. Four search engines, namely Medline, CINAHL, Embase, and PubMed, were used. Publications written in English that described drug utilization in neonatal wards were selected. Assessment of the data was based on the category of the study design, the objective of study and the method used in reporting drug consumption. A total of 20 drug utilization studies were identified, 12 of which focused on all drug classes, while the other eight evaluated antimicrobials. Studies were reported in Europe ( = 7), the United States ( = 6), India ( = 5), Brazil ( = 1), and Iran ( = 1). Substantial variance with regard to study types (study design and methods), data source, and sample size were found among the selected studies. Of the studies included, 45% were cross-sectional or retrospective, 40% were prospective studies, and the remaining 15% were point prevalence surveys. More than 70% of the studies were descriptive studies, describing drug consumption patterns. Fifteen per cent of the descriptive studies evaluated changes in drug utilization patterns in neonates. Volume of units was the most prevalent method used for reporting all drug categories. The ATC/DDD system for reporting drug use was only seen in studies evaluating antimicrobials. The most commonly reported drugs across all studies are anti-infectives for systemic use, followed by drugs for the cardiovascular system, the nervous system and the respiratory system. Ampicillin and gentamicin were the most prescribed antimicrobials in hospitalized neonates. The present review reveals that neonates are exposed to a high number of drugs and various methods are used to report drug consumption in this age group. The best measure of drug consumption to quantify prevalence of drug use in neonates remains to be identified and additional research in this area is warranted.
尽管关于药物在新生儿中使用的安全性和有效性的证据有限,但药物在这一年龄组中仍被广泛使用。然而,关于新生儿尤其是住院新生儿药物消费的信息有限。本文系统回顾了已发表的关于住院新生儿药物利用的研究。进行了一项系统的文献综述,以识别从所使用数据库建立之初至2016年8月发表的观察性研究。使用了四个搜索引擎,即医学索引数据库(Medline)、护理学与健康领域数据库(CINAHL)、荷兰医学文摘数据库(Embase)和医学期刊数据库(PubMed)。选取了用英文撰写的描述新生儿病房药物利用情况的出版物。数据评估基于研究设计的类别、研究目的以及报告药物消费所使用的方法。总共识别出20项药物利用研究,其中12项关注所有药物类别,另外8项评估抗菌药物。研究报告来自欧洲(7项)、美国(6项)、印度(5项)、巴西(1项)和伊朗(1项)。在所选定的研究中,发现研究类型(研究设计和方法)、数据来源和样本量存在很大差异。在所纳入的研究中,45%为横断面研究或回顾性研究,40%为前瞻性研究,其余15%为现患率调查。超过70%的研究为描述性研究,描述药物消费模式。15%的描述性研究评估了新生儿药物利用模式的变化。单位剂量是报告所有药物类别最常用的方法。用于报告药物使用情况的解剖学治疗学及化学分类系统/限定日剂量(ATC/DDD)系统仅在评估抗菌药物的研究中出现。所有研究中最常报告的药物是全身用抗感染药物,其次是心血管系统、神经系统和呼吸系统药物。氨苄西林和庆大霉素是住院新生儿中最常开具的抗菌药物。本综述表明,新生儿接触大量药物,并且在这一年龄组中使用了各种方法来报告药物消费情况。量化新生儿药物使用流行率的最佳药物消费衡量标准仍有待确定,因此有必要在该领域进行更多研究。